Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) has a beta value of 1.21 and has seen 68,256,212 shares traded in the last trading session. The company, currently valued at $62.36 Million, closed the last trade at $1.38 per share which meant it gained $0.3 on the day or 27.78% during that session. The CTXR stock price is -42.75% off its 52-week high price of $1.97 and 71.01% above the 52-week low of $0.4. If we look at the company’s 10-day average daily trading volume, we find that it stood at 10.23 Million shares traded. The 3-month trading volume is 2.72 Million shares.

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) trade information

Sporting 27.78% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Friday, Jun 26 when the CTXR stock price touched $1.97 or saw a rise of 29.95%. Year-to-date, Citius Pharmaceuticals, Inc. shares have moved 35.29%, while the 5-day performance has seen it change 58.17%. Over the past 30 days, the shares of Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) have changed 58.62%. Short interest in the company has seen 952.3 Million shares shorted with days to cover at 350.11.

Wall Street analysts have a consensus price target for the stock at $5.5, which means that the shares’ value could jump 298.55% from current levels. The projected low price target is $4 while the price target rests at a high of $7. In that case, then, we find that the current price level is +407.25% off the targeted high while a plunge would see the stock lose 189.86% from current levels.

Citius Pharmaceuticals, Inc. (CTXR) estimates and forecasts

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -6.2% over the past 5 years. Earnings growth for 2020 is a modest +33.9% while over the next 5 years, the company’s earnings are expected to increase by 0%.